Applications are invited for nine four-year PhD studentship to be funded by the All-island Vaccine Research and Training Alliance (AVACTA), under the HEA North-South Research Programme.
Description: Antimicrobial resistance (AMR) poses a major global risk to human health by causing death, disability, longer hospitalisations, and increased healthcare costs. Vaccines are ideally suited to tackle this problem, improving the lives of people worldwide. The All-island Vaccine Research and Training Alliance (AVACTA) is a hub of excellence aimed to develop effective vaccines against mESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae), a group of bacteria that resist to practically all available antimicrobials, which are considered a major global threat. Complementing vaccine development technologies, AVACTA will also tackle the challenges associated with vaccine hesitancy, developing implementable guidelines to improve vaccine uptake in Ireland and Northern Ireland. AVACTA will provide a unique interdisciplinary PhD program with cross-training in complementary areas of life-sciences, biotechnology, health psychology, public health, ethics, and communication to build capacity in vaccine design, development, and deployment on the island of Ireland. Eligibility criteria for candidates:
We are looking for talented and highly motivated early career researchers with BSc and MSc degrees and experience in microbiology, biology, biochemistry, molecular biology or related disciplines. The successful applicant will be offered a 48-month studentship and be registered as PhD student.
Status: Accepting applications.
Deadline: 1st July 2022.
Start Date: September 2022.
All PhD project details can be found below.